The co-chaperone carboxyl terminus of Hsp70-interacting protein (CHIP) mediates alpha-synuclein degradation decisions between proteasomal and lysosomal pathways
- PMID: 15845543
- DOI: 10.1074/jbc.M503326200
The co-chaperone carboxyl terminus of Hsp70-interacting protein (CHIP) mediates alpha-synuclein degradation decisions between proteasomal and lysosomal pathways
Abstract
Alpha-synuclein is a major component of Lewy bodies, the pathological hallmark of Parkinson disease, dementia with Lewy bodies, and related disorders. Misfolding and aggregation of alpha-synuclein is thought to be a critical cofactor in the pathogenesis of certain neurodegenerative diseases. In the current study, we investigate the role of the carboxyl terminus of Hsp70-interacting protein (CHIP) in alpha-synuclein aggregation. We demonstrate that CHIP is a component of Lewy bodies in the human brain, where it colocalizes with alpha-synuclein and Hsp70. In a cell culture model, endogenous CHIP colocalizes with alpha-synuclein and Hsp70 in intracellular inclusions, and overexpression of CHIP inhibits alpha-synuclein inclusion formation and reduces alpha-synuclein protein levels. We demonstrate that CHIP can mediate alpha-synuclein degradation by two discrete mechanisms that can be dissected using deletion mutants; the tetratricopeptide repeat domain is critical for proteasomal degradation, whereas the U-box domain is sufficient to direct alpha-synuclein toward the lysosomal degradation pathway. Furthermore, alpha-synuclein, synphilin-1, and Hsp70 all coimmunoprecipitate with CHIP, raising the possibility of a direct alpha-synuclein-CHIP interaction. The fact that the tetratricopeptide repeat domain is required for the effects of CHIP on alpha-synuclein inclusion morphology, number of inclusions, and proteasomal degradation as well as the direct interaction of CHIP with Hsp70 implicates a cooperation of CHIP and Hsp70 in these processes. Taken together, these data suggest that CHIP acts a molecular switch between proteasomal and lysosomal degradation pathways.
Similar articles
-
Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation.J Neurosci. 2005 Feb 23;25(8):2002-9. doi: 10.1523/JNEUROSCI.4474-04.2005. J Neurosci. 2005. PMID: 15728840 Free PMC article.
-
Synphilin-1A inhibits seven in absentia homolog (SIAH) and modulates alpha-synuclein monoubiquitylation and inclusion formation.J Biol Chem. 2009 Apr 24;284(17):11706-16. doi: 10.1074/jbc.M805990200. Epub 2009 Feb 17. J Biol Chem. 2009. PMID: 19224863 Free PMC article.
-
UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.J Neurochem. 2004 Jul;90(2):379-91. doi: 10.1111/j.1471-4159.2004.02485.x. J Neurochem. 2004. PMID: 15228595
-
Pathological proteins in Parkinson's disease: focus on the proteasome.J Mol Neurosci. 2004;24(3):425-42. doi: 10.1385/JMN:24:3:425. J Mol Neurosci. 2004. PMID: 15655264 Review.
-
CHIP: a co-chaperone for degradation by the proteasome.Subcell Biochem. 2015;78:219-42. doi: 10.1007/978-3-319-11731-7_11. Subcell Biochem. 2015. PMID: 25487024 Review.
Cited by
-
A central role for inducible heat-shock protein 70 in autoimmune vitiligo.Exp Dermatol. 2013 Sep;22(9):566-9. doi: 10.1111/exd.12183. Epub 2013 Jun 20. Exp Dermatol. 2013. PMID: 23786523 Free PMC article. Review.
-
Molecular chaperones and co-chaperones in Parkinson disease.Neuroscientist. 2012 Dec;18(6):589-601. doi: 10.1177/1073858412441372. Epub 2012 Jul 24. Neuroscientist. 2012. PMID: 22829394 Free PMC article. Review.
-
Autophagy and the ubiquitin-proteasome system in cardiac dysfunction.Panminerva Med. 2010 Mar;52(1):9-25. Panminerva Med. 2010. PMID: 20228723 Free PMC article. Review.
-
Monoubiquitination in Homeostasis and Cancer.Int J Mol Sci. 2022 May 25;23(11):5925. doi: 10.3390/ijms23115925. Int J Mol Sci. 2022. PMID: 35682605 Free PMC article. Review.
-
Lanosterol Suppresses the Aggregation and Cytotoxicity of Misfolded Proteins Linked with Neurodegenerative Diseases.Mol Neurobiol. 2018 Feb;55(2):1169-1182. doi: 10.1007/s12035-016-0377-2. Epub 2017 Jan 19. Mol Neurobiol. 2018. PMID: 28102469
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous